Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Compound Pharmacy Bill Will Block FDA Authority Over Small Operations September 16, 2013 Irvin Jackson Add Your Comments A recently proposed House bill would restrict the FDA’s authority over traditional compounding pharmacies, but would also create a new sub-class of pharmacy that is a blend between a compounder and a drug manufacturer, which some critics have suggested will put the public at even greater risk.  The legislation, known as the Compounding Clarity Act (H.R. 3098) (PDF), was filed on September 12 by House representatives Morgan Griffith, a Virginia Republican, Gene Greene, a Texas Democrat, and Diana Degette, a Colorado Democrat. The bill comes about a year after health investigators discovered a nationwide fungal meningitis outbreak that was linked to contaminated epidural steroid injections distributed throughout the United States by a single a compounding pharmacy in Massachusetts. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The proposed legislation, which is similar to one already proposed in the U.S. Senate, would undercut the FDA’s recent enforcement efforts to prevent another outbreak by blocking its authority over traditional compounding pharmacies. However, it would give the agency increased authority over large-scale compounders, and set guidelines over which compounding pharmacies would be exempt from FDA oversight and which would not. The fungal meningitis outbreak is blamed for the deaths of 64 people nationwide and is believed to have sickened at least 760 others. The outbreak was tracked back to the New England Compounding Center (NECC), which was forced to recall its drugs and shut down. The pharmacy has since filed for bankruptcy under the weight of impending lawsuits. During the investigation, it was discovered that the FDA and Massachusetts health officials knew there was a problem with NECC, but did not take strong enough action. Since then, the FDA and state agencies have been hammering down on compounding pharmacies, resulting in numerous recalls. However, a number of court decisions throughout the years have left the FDA’s authority over compounding pharmacies in doubt, and some have resisted the agency’s efforts to recall potentially unsafe drugs. Traditionally, compounding pharmacies are small scale operations overseen by state boards. They create specific drug compounds on a per-prescription basis for local hospitals when that drug is not available elsewhere. However, more and more have begun mass producing drugs and distributing them nationally, operating as what some call “stealth drug manufacturers,” meaning their drugs get made without federal oversight. This appears to have been the case with NECC, which distributed 17,000 epidural steroid injections nationwide that were later linked to the fungal meningitis outbreak. Bill Creates New Type of Compounding Pharmacy The House bill would define which compounding pharmacies are traditional operations that work on a small scale and would be exempt from the FDA’s oversight, while setting standards of operation for those facilities. It would also decide which were non-traditional, large-scale operations that were subject to more stringent regulations. Critics of the proposed plan say that the FDA should have jurisdiction over all compounding pharmacies, and that there should not be a new, hybrid, category of large-scale compound drug manufacturer. Instead, those operations should be subject to the same new drug approval rules as drug manufacturers. Public watchdog groups, like Public Citizen, say the bills endanger the public by increasing the risk of another outbreak. However, the bills have been endorsed by lobbying groups for pharmacists like the National Community Pharmacists Association, which criticized the Senate version of the bill for allowing the FDA to step in when compounding pharmacies manufacture an FDA-approved drug because it is in low supply. Tags: Compounding Pharmacy, Congress, Fungal Meningitis, Infection, Pharmacy Error Image Credit: ||| More Lawsuit Stories Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall June 18, 2025 Centralization of Ozempic, Wegovy NAION Lawsuits Sought in New Jersey State Court June 18, 2025 Fosamax Femur Fracture Lawsuits Set To Move Forward After Supreme Court Refuses Appeal June 18, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermEmailThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: yesterday) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024) Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 2 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025) Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: 3 days ago) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)
Zantac Cancer Lawsuits Continue To Be Filed More Than 5 Years After Recall (Posted: yesterday) A man diagnosed with multiple forms of cancer has filed a Zantac lawsuit, blaming Boehringer Ingelheim for failing to adequately warn about the recalled heartburn drug’s health risks. MORE ABOUT: ZANTAC CANCER LAWSUITSJury Hears Zantac Cancer Evidence in Illinois Trial Against Boehringer Ingelheim (02/05/2025)Zantac Bladder Cancer Lawsuit Trial Ends With Hung Jury in California (11/22/2024)GSK To Pay $2.2 Billion To Settle Zantac Cancer Lawsuits Brought by 80,000 Consumers (10/10/2024)
Enfamil NEC Lawsuit Filed After Newborn Suffers ‘Nearly Total Bowel Necrosis’ (Posted: 2 days ago) Necrotizing enterocolitis caused by Enfamil resulted in a newborn suffering life-long bowel injuries, according to a lawsuit filed by his mother. MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITReckitt Benckiser Faces Class Action Lawsuit Over Enfamil NEC Risks (06/12/2025)NEC Infant Formula Lawyers To Meet With MDL Judge Following Dismissal of First Bellwether Trial (05/29/2025)FDA To Investigate Whether Infant Formula Products Provide Enough Nutrition (05/16/2025)
Judge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (Posted: 3 days ago) A California judge has ordered parties involved in a hair dye bladder cancer lawsuit filed against major cosmetic companies to meet for the first time this week to discuss the case. MORE ABOUT: HAIR DYE LAWSUITLawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)Hair Color Lawsuit Alleges Bladder Cancer Caused by Salon Dye (04/25/2025)